sc 58125 has been researched along with remifentanil in 1 studies
| Studies (sc 58125) | Trials (sc 58125) | Recent Studies (post-2010) (sc 58125) | Studies (remifentanil) | Trials (remifentanil) | Recent Studies (post-2010) (remifentanil) |
|---|---|---|---|---|---|
| 93 | 0 | 15 | 3,830 | 1,644 | 1,886 |
| Protein | Taxonomy | sc 58125 (IC50) | remifentanil (IC50) |
|---|---|---|---|
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ni, K; Peng, Y; Zang, T; Zhou, L; Zhou, X | 1 |
1 other study(ies) available for sc 58125 and remifentanil
| Article | Year |
|---|---|
COX-2 contributed to the remifentanil-induced hyperalgesia related to ephrinB/EphB signaling.
Topics: Animals; Cyclooxygenase 2; Disease Models, Animal; Ephrins; Hyperalgesia; Injections, Spinal; Mice; Pyrazoles; Receptors, N-Methyl-D-Aspartate; Remifentanil; Spinal Cord | 2019 |